Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country, P.O. Box 644, 48980 Bilbao, Spain.
Respiratory Department, Cruces University Hospital, P.O. Box 644, 48903 Barakaldo, Spain.
Medicina (Kaunas). 2021 Jul 19;57(7):729. doi: 10.3390/medicina57070729.
Sphingolipids are both structural molecules that are essential for cell architecture and second messengers that are involved in numerous cell functions. Ceramide is the central hub of sphingolipid metabolism. In addition to being the precursor of complex sphingolipids, ceramides induce cell cycle arrest and promote cell death and inflammation. At least some of the enzymes involved in the regulation of sphingolipid metabolism are altered in carcinogenesis, and some are targets for anticancer drugs. A number of scientific reports have shown how alterations in sphingolipid pools can affect cell proliferation, survival and migration. Determination of sphingolipid levels and the regulation of the enzymes that are implicated in their metabolism is a key factor for developing novel therapeutic strategies or improving conventional therapies. The present review highlights the importance of bioactive sphingolipids and their regulatory enzymes as targets for therapeutic interventions with especial emphasis in carcinogenesis and cancer dissemination.
鞘脂类物质既是细胞结构的必需组成部分,也是参与多种细胞功能的第二信使。神经酰胺是鞘脂代谢的中心枢纽。神经酰胺不仅是复杂鞘脂的前体,还能诱导细胞周期停滞,并促进细胞死亡和炎症。在癌变过程中,至少有一些参与调节鞘脂代谢的酶发生了改变,其中一些是抗癌药物的靶点。许多科学研究报告表明,鞘脂库的改变如何影响细胞增殖、存活和迁移。测定鞘脂水平以及调节参与其代谢的酶是开发新的治疗策略或改善传统疗法的关键因素。本综述强调了生物活性鞘脂及其调节酶作为治疗干预靶点的重要性,特别是在癌变和癌症转移方面。